Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.”

60 pharma patents match "TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 60
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 60 pharmaceutical patents matching "TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

60 results for “TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.” · 30,257 patents in full index Clear search

  1. US 10465004

    Frizzled receptor antibodies for treatment of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  2. US 10266579

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted
  3. US 10179151

    Methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted
  4. US 10113170

    Preventing and treating inflammatory skin diseases

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted
  5. US 10028999

    PAR-1 based therapeutic conjugates and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted
  6. US 10022382

    RNA polymerase I inhibitors and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  7. US 9987326

    Klotho protein and related compounds for the treatment and diagnosis of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  8. US 9982236

    Cell populations, methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  9. US 9975944

    Synthetic peptides for the treatment of autoimmune diseases

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  10. US 9808488

    Isolated populations of renal stem cells and methods of isolating and using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  11. US 9782387

    Compositions and methods for treating hematological malignancies

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  12. US 9777050

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted
  13. US 9770469

    Methods of reprogramming renal cells

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  14. US 9771567

    Klotho variant polypeptides

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  15. US 9758831

    Methods of predicting clinical course and treating multiple sclerosis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  16. US 9737571

    Compositions of aquatic origin for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  17. US 9732124

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  18. US 9688697

    RNA polymerase I inhibitors and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted
  19. US 9610331

    Methods for hematopoietic precursor mobilization

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  20. US 9492480

    Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  21. US 9481894

    Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  22. US 9261507

    Anti CEACAM1 antibodies and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  23. US 9238838

    Microrna patterns for the diagnosis, prognosis and treatment of melanoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  24. US 9180152

    Method for treating psoriasis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted